In recent years pyrimidine derivatives have received significant attention owing to their diverse range of biological properties particularly being antifungal[@CIT1], antitubercular[@CIT2], antibacterial[@CIT3][@CIT4], antiviral[@CIT5]--[@CIT8], anticancer[@CIT9] and antioxidant[@CIT10]. 2,5-Disubstituted-1,3,4-thiadiazoles represent one of the most active classes of compounds possessing wide spectrum of biological activities. 2,5-Disubstituted-1,3,4-thiadiazole derivatives exhibit *in vitro* antimycobacterial[@CIT11], antibacterial[@CIT12], anticancer[@CIT13][@CIT14] and antioxidant[@CIT15] properties. Considering the above facts, the goal of the present study was to combine disubstituted pyrimidines with 1,3,4-thiadiazole residues in order to develop hybrid molecules with potential of enhanced activity and to test their antioxidant and antitumor activities.

Melting points were taken in open capillary tubes and are uncorrected. The IR spectra (KBr, cm^−1^) were recorded on a Shimadzu FTIR 800 series spectrophotometer and ^1^H NMR spectra (CDCl~3~) on Varian EM 390 MHz spectrometer using TMS as internal standard. Mass spectra were recorded on Shimadzu 2010A LC-MS system. The reactions were monitored by thin layer chromatography using silica gel plates and detected by UV chamber and iodine as visualizing agent. The purity of the compounds was checked on silica gel precoated plates. All the solvents used were purified according to the standard methods[@CIT16]. Phenyl isothiocyanate was prepared according to the standard method[@CIT17].

For the preparation of 4, 6-disubstituted pyrimidine-2-thiols (2a-i) a mixture of appropriate chalcones (1a-i, [Scheme 1](#F0001){ref-type="fig"}) (0.01 mol) and thiourea (0.01 mol) in ethanol (50 ml) and sodium hydroxide (0.01 mol) dissolved in minimum quantity of water was refluxed on a water bath for 12 h and poured into 250 ml of cold water. The solid that separated in each case was filtered, washed with water and recrystallized from ethyl acetate ([Table 1](#T0001){ref-type="table"}); 2a: IR (KBr, cm^−1^): 3095 (aromatic C-H str.), 2830 (S-H str.), 1640 (C=N), 1590, 1610 (aromatic C=C str.), 1520 (C-N str.); MS: m/z 264 (M^+^); Anal. Calcd. for C~16~H~12~N~2~S: C, 72.72; H, 4.54; N, 10.60. Found: C, 72.75; H, 4.58; N, 10.56%; 2b: IR (KBr, cm^−1^): 3120 (aromatic C-H str.), 2840 (S-H str.), 1651 (C=N), 1582, 1606 (aromatic C=C str.), 1516 (C-N str.), 1265 (C-O-C); ^1^H NMR (CDCl~3~): δ 9.72 (s, 1H, SH), 6.81-8.32 (m, 11H, aromatic and heterocyclic), 3.75 (s, 3H, OCH~3~); MS: m/z 294 (M^+^); Anal. Calcd. for C~17~H~14~N~2~OS: C, 69.38; H, 4.76; N, 9.52. Found: C, 69.37; H, 4.81; N, 9.58%; 2c: IR (KBr, cm^−1^): 3330 (OH), 3088 (aromatic C-H str.), 2842 (S-H str.), 1649 (C=N), 1608 (aromatic C=C str.), 1518 (C-N str.); MS: m/z 280 (M^+^); Anal. Calcd. for C~16~H~12~N~2~OS: C, 68.57; H, 4.28; N, 10.00. Found: C, 68.61; H, 4.31; N, 9.97%; 2d: IR (KBr, cm^−1^): 3360 (OH), 3082 (aromatic C-H str.), 2835 (S-H str.), 1635 (C=N), 1580, 1608 (aromatic C=C str.), 1524 (C-N str.), 1280 (C-O-C); MS: m/z 310 (M^+^); Anal. Calcd. for C~17~H~14~N~2~SO~2~: C, 65.80; H, 4.51; N, 9.03. Found: C, 65.68; H, 4.54; N, 9.10%; 2e: IR (KBr, cm^−1^): 3082 (aromatic C-H str.), 2820 (S-H str.), 1635 (C=N), 1580, 1608 (aromatic C=C str.), 1524 (C-N str.), 1345 (NO~2~), 1275 (C-O-C); MS: m/z 339 (M^+^); Anal. Calcd. for C~17~H~13~N~3~O~3~S: C, 60.17; H, 3.83; N, 12.38. Found: C, 60.12; H, 3.85; N, 12.33%; 2f: IR (KBr, cm^−1^): 3328 (OH), 3086 (aromatic C-H str.), 2840 (S-H str.), 1644 (C=N), 1580, 1605 (aromatic C=C str.), 1524 (C-N str.); MS: m/z 280 (M^+^); Anal. Calcd. for C~16~H~12~N~2~ OS: C, 68.57; H, 4.28; N, 10.00. Found: C, 68.63; H, 4.34; N, 9.93%; 2g: IR (KBr, cm^−1^): 3330 (OH), 3060 (aromatic C-H str.), 3010 (C=C, alkene), 2825 (S-H str.), 1615 (C=N), 1598 (aromatic C=C str.), 1524 (C-N str.); MS: m/z 306 (M^+^); Anal. Calcd. for C~18~H~14~N~2~OS : C, 70.58; H, 4.57; N, 9.15. Found: C, 70.60; H, 4.53; N, 9.19%; 2h: IR (KBr, cm^−1^): 3310 (OH), 3072 (aromatic C-H str.), 2833 (S-H str.), 1618 (C=N), 1585 (aromatic C=C str.), 1520 (C-N str.), 1105 (C-O-C); MS: m/z 270 (M^+^); Anal. Calcd. for C~14~H~10~N~2~O~2~S: C, 62.22; H, 3.70; N, 10.37. Found: C, 62.28; H, 3.67; N, 10.29%; 2i: IR (KBr, cm^−1^): 3075 (aromatic C-H str.), 2830 (S-H str.), 1610 (C=N), 1605 (aromatic C=C str.), 1522 (C-N str.), 1352 (NO~2~); MS: m/z 334 (M^+^); Anal. Calcd. for C~18~H~12~N~3~O~2~S : C, 64.67; H, 3.59; N, 12.57. Found: C, 64.60; H, 3.62; N, 12.61%.

![Synthesis of {\[(4,6-disubstitutedpyrimidine-2-yl)thio\] methyl}-N-phenyl-1,3,4-thiadiazol-2-amine\
R= -C~6~H~5~, 2-OH.C~6~H~4~ and 4-NO~2~.C~6~H~4~, R\'= -C~6~H~5~, 4-OCH~3~.C~6~H~4~, 2-OH. C~6~H~4~, -CH=CH.C~6~H~5~ and 3-furyl](IJPhS-70-672-g001){#F0001}

###### 

CHARACTERIZATION DATA OF SYNTHESIZED COMPOUNDS[d](#T000F2){ref-type="table-fn"}

  Compd.   R                  R\'                 Mol. Formula             M.P. °C   %Yield[a](#T000F1){ref-type="table-fn"}
  -------- ------------------ ------------------- ------------------------ --------- -----------------------------------------
  1a       C~6~H~5~           C~6~H~5~            C~15~H~12~O              57        80
  1b       C~6~H~5~           4-OCH~3~.C~6~H~4~   C~16~H~14~O~2~           72        85
  1c       C~6~H~5~           2-OH.C~6~H~4~       C~15~H~12~O~2~           66        81
  1d       2-OH.C~6~H~4~      4-OCH~3~.C~6~H~4~   C~6~H~14~O~3~            75        78
  1e       4-NO~2~.C~6~H~4~   4-OCH~3~.C~6~H~4~   C~16~H~13~O~4~N          77        65
  1f       2-OH.C~6~H~4~      C~6~H~5~            C~15~H~12~O~2~           60        85
  1g       2-OH.C~6~H~4~      C~6~H~5~CH=CH-      C~17~H~14~O~2~           69        55
  1h       2-OH.C~6~H~4~      3-furyl             C~13~H~10~O~3~           82        67
  1i       4-NO~2~.C~6~H~4~   C~6~H~5~.CH=CH-     C~17~H~13~O~3~N          78        60
  2a       C~6~H~5~           C~6~H~5~            C~16~H~12~N~2~S          165       81
  2b       C~6~H~5~           4-OCH~3~.C~6~H~4~   C~17~H~14~N~2~OS         80        75
  2c       C~6~H~5~           2-OH.C~6~H~5~       C~16~H~12~N~2~OS         130       56
  2d       2-OH.C~6~H~4~      4-OCH~3~.C~6~H~4~   C~17~H~14~N~2~O~2~S      120       84
  2e       4-NO~2~.C~6~H~4~   4-OCH~3~.C~6~H~4~   C~17~H~13~N~3~O~3~S      140       96
  2f       4-OH.C~6~H~4~      C~6~H~5~            C~16~H~12~N~2~OS         175       89
  2g       2-OH.C~6~H~4~      C~6~H~5~.CH=CH-     C~18~H~14~N~2~OS         265       77
  2h       2-OH.C~6~H~4~      3-Furyl             C~14~H~10~N~2~O~2~S      101       82
  2i       4-NO~2~.C~6~H~4~   C~6~H~5~.CH=CH-     C~18~H~12~N~3~O~2~S      270       63
  3a       C~6~H~5~           C~6~H~5~            C~20~H~18~N~2~O~2~S      118       86
  3b       C~6~H~5~           4-OCH~3~.C~6~H~4~   C~21~H~20~N~2~O~3~S      198       65
  3c       C~6~H~5~           2-OH.C~6~H~4~       C~20~H~18~N~2~O~3~S      212       57
  4a       C~6~H~5~           C~6~H~5~            C~18~H~16~N~4~OS         202       65
  4b       C~6~H~5~           4-OCH~3~.C~6~H~4~   C~19~H~18~N~4~O~2~S      199       55
  4c       C~6~H~5~           2-OH.C~6~H~4~       C~18~H~16~N~4~O~2~S      215       61
  5a       C~6~H~5~           C~6~H~5~            C~25~H~21~N~5~OS~2~      186       62
  5b       C~6~H~5~           4-OCH~3~.C~6~H~4~   C~26~H~23~N~5~O~2~S~2~   189       53
  5c       C~6~H~5~           2-OH.C~6~H~4~       C~25~H~21~N~5~O~2~S~2~   175       64
  6a       C~6~H~5~           C~6~H~5~            C~25~H~19~N~5~S~2~       198       56
  6b       C~6~H~5~           4-OCH~3~.C~6~H~4~   C~26~H~21~N~5~OS~2~      210       51
  6c       C~6~H~5~           2-OH.C~6~H~4~       C~25~H~19~N~5~OS~2~      235       58

Isolated yield, compounds 1a-i were synthesized by the known procedure[@CIT21]

all compounds showed satisfactory elemental analysis

Preparation of ethyl \[(4,6-disubstituted pyrimidine-2-yl) thio\] acetates (3a-c) was achieved by mixing equimolar quantities of 4,6-disubstituted pyrimidine-2-thiols (2a-c) (0.017 mol), ethyl chloroacetate (2.017 g, 0.017 mol) and anhydrous potassium carbonate (1.10 g, 0.01 mol) in dry acetone (15 ml) and refluxing on a water bath for about 13 h. The mixture was then diluted with benzene and washed with water. The organic layer was dried (Na~2~SO~4~) and the solvent was removed under reduced pressure. The resulting solid in each case was recrystallized from benzene:petroleum ether (1:1) ([Table 1](#T0001){ref-type="table"}); 3a: IR (KBr, cm^−1^): 3065 (aromatic C-H str.), 2910, 2886 (aliphatic C-H str.), 1745 (\>C=O of ester), 712 (C-S-C); MS m/z: 350 (M^+^); Anal. Calcd. for C~20~H~18~N~2~O~2~S: C, 68.57; H, 5.14; N, 8.00. Found: C, 68.61; H, 5.18; N, 7.95%; 3b: IR (KBr, cm^−1^): 3061 (aromatic C-H str.), 2912, 2875 (aliphatic C-H str.), 1736 (\>C=O of ester), 1240 (C-O-C), 710 (C-S-C); ^1^H NMR (CDCl~3~): δ 6.82-8.10 (m, 10H, aromatic and heterocyclic), 4.32 (q, 2H, COO[CH]{.ul}~2~CH~3~), 4.12 (s, 2H, S-CH~2~-CO), 3.72 (s, 3H, OCH~3~), 1.05 (t, 3H, -COOCH~2~[CH]{.ul}~3~); MS m/z: 380 (M^+^); Anal. Calcd. for C~21~H~20~N~2~O~3~S: C, 66.31; H, 5.26; N, 7.36. Found: C, 66.25; H, 5.32; N, 7.29%; 3c: IR (KBr, cm^−1^): 3320 (OH), 3070 (aromatic C-H str.), 2930, 2885 (aliphatic C-H str.), 1742 (\>C=O of ester), 715 (C-S-C); MS m/z: 366 (M^+^); Anal. Calcd. for C~20~H~18~N~2~O~3~S: C, 65.57; H, 4.91; N, 7.65. Found: C, 65.63; H, 5.14; N, 7.58%.

For preparation of 2-\[(4,6-disubstituted pyrimidine-2-yl) thio\] acetohydrazides (4a-c), a solution of the appropriate esters (3a-c) (0.01 mol), hydrazine hydrate (3.5 ml) and ethanol (25 ml) was refluxed on a water bath for about 10 h. The solvent was then removed under reduced pressure and the residue obtained in each case was recrystallized from methanol ([Table 1](#T0001){ref-type="table"}); 4a: IR (KBr, cm^−1^): 3420, 3375 (NH-NH~2~) 1660 (\>C=O, amido), 1622 (C=N str.), 1605 (aromatic C=C), 715 (C-S-C); MS m/z: 336 (M^+^); Anal. Calcd. for C~18~H~16~N~4~OS: C, 64.28; H, 4.76; N, 16.66. Found: C, 64.33; H, 4.69; N, 16.71%; 4b: IR (KBr, cm^−1^): 3438, 3380, 3310 (NH-NH~2~) 1653 (\>C=O, amido), 1642 (C=N str.), 1598 (aromatic C=C), 1250 (C-O-C), 712 (C-S-C); ^1^H NMR (CDCl~3~): δ 9.51 (s, 1H, CONH), 6.82-7.91 (m, 10H, aromatic and heterocyclic), 6.49 (bs, 2H, NH~2~), 4.20 (s, 2H, S-CH~2~-CO), 3.71 (s, 3H, OCH~3~); MS m/z: 366 (M^+^); Anal. Calcd. for C~19~H~18~N~4~O~2~S: C, 62.29; H, 4.92; N, 15.30. Found: C, 62.31; H, 4.87; N, 15.29%; 4c: IR (KBr, cm^−1^): 3380 (OH), 3345, 3320 (NH-NH~2~), 1668 (\>C=O, amido), 1622 (C=N str.), 1598 (aromatic C=C), 711 (C-S-C); MS m/z: 352 (M^+^); Anal. Calcd. for C~18~ H~16~N~4~O~2~S: C, 61.36; H, 4.54; N, 15.90. Found: C, 61.41; H, 4.59; N, 15.83%.

For preparation of 2-\[(4, 6-disubstituted pyrimidine-2-yl) thio\] acetyl-N-phenylhydrazine carbothiamide (5a-c), a mixture of the acid hydrazides (4a-c) (0.01 mol) and phenylisothiocyanate (0.0015 mol) in ethanol (10 ml) was refluxed on a water bath for about 8 h. The solution was allowed to reach ambient temperature and the resulting solid in each case was collected and recrystallized from methanol ([Table 1](#T0001){ref-type="table"}); 5a: IR (KBr, cm^−1^): 3225, 3215, 3180 (N-H), 3035, (aromatic C-H str.), 1670 (\>C=O), 1625 (C=N), 1605 (aromatic C=C str.), 1450 (\>C=S), 718 (C-S-C); MS m/z: 471 (M^+^); Anal. Calcd. for C~25~H~21~N~5~OS~2~: C, 63.69; H, 4.45; N, 14.86. Found: C, 63.72; H, 4.37; N, 14.79%; 5b: IR (KBr, cm^−1^): 3120-3218 (N-H), 3024 (aromatic C-H str.), 1681 (\>C=O), 1667 (C=N), 1605 (aromatic C=C str.), 1453 (\>C=S), 1255 (C-O-C), 710 (C-S-C); ^1^H NMR (CDCl~3~): δ 8.20-10.12 (m, 3H, NH.NH.CS.NH), 7.21-7.92 (m, 15H, aromatic and heterocyclic), 4.21(s, 2H, S-CH~2~-CO), 3.48 (s, 3H, OCH~3~); MS m/z: 501 (M^+^); Anal. Calcd. for C~26~H~23~N~5~O~2~S~2~: C, 62.27; H, 4.59; N, 13.97. Found: C, 61.98; H, 4.48; N, 13.89%; 5c: IR (KBr, cm^−1^): 3340 (OH), 3218, 3205, 3185 (N-H), 3045, (aromatic C-H str.), 1695 (\>C=O), 1625 (C=N), 1598 (aromatic C=C str.), 1448 (\>C=S), 714 (C-S-C); MS m/z: 487 (M^+^); Anal. Calcd. for C~25~H~21~N~5~O~2~S~2~: C, 61.60; H, 4.31; N, 14.37. Found: C, 61.67; H, 4.39; N, 14.31%.

For preparation of 5-{\[(4,6-disubstituted pyrimidine-2-yl) thio\] methyl}-N-phenyl-1,3,4-thiadiazol-2-amine (6a-c), a mixture of the appropriate thiosemicarbazides (5a-c) (0.001 mol) in cold concentrated sulphuric acid (3 ml) was stirred for 10 min the resulting solution was then allowed to reach ambient temperature and poured cautiously into ice cold water. The reaction mixture was made alkaline to pH 8 with aqueous ammonia and the precipitated product in each case was collected washed with cold water and recrystallized from ethanol ([Table 1](#T0001){ref-type="table"}); 6a: 3395 (N-H), 3095 (aromatic C-H str.), 2955 (C-H str.), 1620 (C=N, str.), 1605 (aromatic C=C str.), 740 (C-S-C, thiadiazole), 710 (C-S-CH~2~); MS m/z: 453 (M^+^); Anal. Calcd. for C~25~H~19~N~5~S~2~: C, 66.22; H, 4.19; N, 15.45. Found: C, 66.29; H, 4.14; N, 15.39%; 6b: 3440 (N-H), 3211 (aromatic C-H str.), 2939 (C-H str.), 1665 (C=N, str.), 1599 (aromatic C=C str.), 1248 (C-O-C), 746 (C-S-C, thiadiazole), 708 (C-S-CH~2~); ^1^H NMR (CDCl~3~): δ 9.3 (s, 1H, NH), 7.21-8.32 (m, 15H, aromatic and heterocyclic), 3.38 (s, 3H, OCH~3~), 3.61 (s, 2H, -CH~2~-); MS m/z: 483 (M^+^); Anal. Calcd. for C~26~H~21~N~5~OS~2~: C, 64.59; H, 4.34; N, 14.49. Found: C, 64.61; H, 4.42; N, 14.51%; 6c: 3380 (N-H), 3345 (OH), 3070 (aromatic C-H str.), 2975 (C-H str.), 1612 (C=N, str.), 1610 (aromatic C=C str.), 726 (C-S-C, thiadiazole), 712 (C-S-C); MS m/z: 469 (M^+^); Anal. Calcd. for C~25~H~19~N~5~OS~2~: C, 63.96; H, 4.05; N, 14.92. Found: C, 64.11; H, 4.09; N, 14.89%.

Determination of *In vitro* antioxidant activity was done by DPPH (1,1-diphenyl-2-picrylhydrazyl)[@CIT18] and nitric oxide[@CIT19] free radical scavenging methods. The methods were used to screen compounds (2a-i) and (6a-c) for the antioxidant activity. Ascorbic acid and rutin were used as reference standards at a concentration level of 100 μg/ml. Results are presented in [Table 2](#T0002){ref-type="table"}.

###### 

*IN VITRO* ANTICANCER AND ANTIOXIDANT ACTIVITIES OF COMPOUNDS (2A-I) AND (6A-C)

  Compd.   Antioxidant activity   Average percent growth values[\*\*](#T000F4){ref-type="table-fn"} at 20 μM in MCF-7 cell line   
  -------- ---------------------- ----------------------------------------------------------------------------------------------- -------
  2a       \>500                  105                                                                                             67.77
  2b       \>500                  160                                                                                             13.33
  2c       56                     95                                                                                              0
  2d       50.5                   90                                                                                              79.98
  2e       84                     \>500                                                                                           34.44
  2f       \>500                  125                                                                                             94.44
  2g       60                     200                                                                                             77.50
  2h       84                     \>500                                                                                           43.55
  2i       \>500                  \>500                                                                                           97.4
  6a       82                     143                                                                                             68.54
  6b       92                     87                                                                                              12.55
  6c       78                     \>500                                                                                           58.50
           18                     69                                                                                              \--
           (ascorbic acid)        (rutin)                                                                                         

Average of three determinations, both test compounds and standard were tested at 100 μg/ml, IC~50~ concentration of the test compound causing 50% decrease of activity against control.

Mean of two determinations, ^a^zero indicates that no cells have died.

Antitumor activity of the compounds was evaluated by tryphan blue dye exclusion technique[@CIT20] against human breast cancer MCF-7 cell line at 20 μM concentration. Primary screening of the compounds was done to indicate whether a substance possessed enough activity at this concentration to inhibit cell growth by 50%. Results are presented in [Table 2](#T0002){ref-type="table"}.

Chalcones (1a-i) required as starting material were prepared[@CIT21] by stirring equimolar solution of various substituted acetophenones and araldehydes in the presence of sodium hydroxide in ethanol at room temperature ([Scheme 1](#F0001){ref-type="fig"}). Solution in ethanol of chalcones (1a-i) and thiourea in the presence of sodium hydroxide was refluxed on a water bath to yield 4,6-disubstituted pyrimidine-2-thiols (2a-i). When thiols (2a-c) and ethyl chloroacetate was refluxed in the presence of anhydrous sodium carbonate resulted in the formation of ethyl \[(4,6-disubstituted pyrimidine-2-yl) thio\] acetates (3a-c). Compounds (3a-c), hydrazine hydrate in ethanol as a reaction media afforded 2-\[(4,6-disubstitutedpyrimidine-2-yl) thio\] acetohydrazides (4a-c), which on condensation with phenyl isothiocyanate in ethanol gave 2-{\[(4,6-disubstituted pyrimidine-2-yl) thio\] acetyl}-N-phenylhydrazinecarbothioamides (5a-c). The compounds (5a-c) on treatment with concentrated sulphuric acid yielded 5-{\[(4,6-disubstituted pyrimidine-2-yl) thio\] methyl}-N-phenyl-1, 3, 4-thiadiazol-2-amines (6a-c). All the compounds synthesized were characterized by their elemental analysis, IR and ^1^H NMR spectra. The physical and chemical data are presented in [Table 1](#T0001){ref-type="table"}. In the IR spectrum of 2b, the presence of band at 2840 cm^−1^ (SH) and the absence of band due to \>C=O confirmed the formation of pyrimidine-2-thiol moiety. The appearance of singlet at δ 9.72 due to SH also confirmed the formation of 2b. The IR spectrum of 5b exhibited band at 1681 cm^−1^ (\>C=O), 1667 cm^−1^ (\>C=N) and 3120-3218 cm^−1^ due to N-H. The ^1^H NMR spectrum of 5b exhibited the aromatic and heterocyclic protons as a multiplet integrating for 15 protons from δ 7.21-7.92 and a multiplet integrating for 3 protons from δ 8.20-10.12 due to NH.NH.CS.NH. In the IR spectrum of 6b, the disappearance of bands at 1681 cm^−1^ (\>C=O) and 1453 cm^−1^ (\>C=S) and the appearance of band at 746 cm^−1^ (C-S-C) confirmed the formation of thiadiazole ring. The ^1^H NMR spectrum of 6b exhibited the aromatic and heterocyclic protons as a multiplet integrating for 15 protons from δ 7.21-8.32 and a singlet at δ 9.3 integrating for one proton due to NH. In the mass spectra, the molecular ion peak at 483 (M^+^) also confirmed the formation of titled compound 6b.

Compound 2c, 2d, 2g and 6b showed moderate DPPH free radical scavenging activity while all other compounds were found to be less active. Compounds 2c, 2d and 6b showed moderate nitric oxide free radical scavenging activity and all other compounds were found to be less active. As shown in [Table 2](#T0002){ref-type="table"} compounds 2b, 2c and 6b exhibited significant activity against human breast cancer MCF-7 cell line, while compounds 2e and 2h showed moderate cytotoxicity.
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